Valuation: Ion Beam Applications, SA

Market Cap 465M 536M 436M 399M 753M 51.09B 762M 5.1B 2B 25.53B 2.01B 1.97B 84.96B P/E 2026 *
20.1x
P/E 2027 * 15.6x
Enterprise Value 507M 584M 475M 434M 820M 55.66B 831M 5.55B 2.18B 27.81B 2.19B 2.15B 92.56B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.74x
Free-Float
60.92%
Yield 2026 *
1.84%
Yield 2027 * 2.08%
1 week+5.97%
Current month+5.97%
1 month+0.74%
3 months+11.11%
6 months+6.53%
Current year+24.53%
1 week 19
Extreme 19
19
1 month 17.93
Extreme 17.93
19.62
Current year 15
Extreme 15
20.1
1 year 11.45
Extreme 11.45
20.1
3 years 8.65
Extreme 8.65
20.1
5 years 8.65
Extreme 8.65
23.45
10 years 6.34
Extreme 6.34
61.6
Manager TitleAgeSince
Chief Executive Officer 58 2012-04-30
Chief Tech/Sci/R&D Officer 78 1986-03-27
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 65 2013-04-30
Director/Board Member 78 1991-04-30
Director/Board Member 58 2012-04-30
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+5.97% - - 544M
+0.38%+0.56%+29.20%+5.72% 214B
+0.16%+1.94%+2.46%-21.50% 140B
-0.40%+5.88%-21.17%+20.82% 133B
+3.27%+7.17%-52.11%-2.80% 69.19B
+0.39%+2.76%+13.62%+12.28% 51.28B
-0.36%+5.11%-14.27%-20.67% 50.43B
+0.16%+1.90%+24.83%+11.91% 39.85B
-0.08%+5.10%+43.92%+37.88% 39.27B
-0.35%+7.04%-20.40%+24.54% 32.32B
Average +0.32%+4.27%+0.68%+7.58% 85.43B
Weighted average by Cap. +0.35%+3.41%+2.87%+4.05%

Financials

2026 *2027 *
Net sales 633M 729M 593M 542M 1.02B 69.47B 1.04B 6.93B 2.72B 34.71B 2.74B 2.68B 116B 647M 746M 606M 554M 1.05B 71.06B 1.06B 7.09B 2.78B 35.5B 2.8B 2.74B 118B
Net income 22.03M 25.39M 20.63M 18.87M 35.63M 2.42B 36.09M 241M 94.72M 1.21B 95.32M 93.25M 4.02B 31.03M 35.75M 29.05M 26.58M 50.17M 3.41B 50.83M 340M 133M 1.7B 134M 131M 5.66B
Net Debt 41.62M 47.97M 38.98M 35.65M 67.31M 4.57B 68.19M 456M 179M 2.28B 180M 176M 7.6B 15.92M 18.34M 14.9M 13.63M 25.74M 1.75B 26.07M 174M 68.42M 873M 68.86M 67.36M 2.91B
Logo Ion Beam Applications, SA
Ion Beam Applications, SA (IBA) is gespecialiseerd in het ontwerp, de vervaardiging en de verkoop van apparatuur voor de diagnose en de behandeling van kanker. De omzet (voor binnen de groep afgestoten activiteiten) per productfamilie wordt als volgt onderverdeeld: - apparatuur en systemen voor diagnose en therapeutische behandeling (89,4%): apparatuur voor protontherapie (59,8% van de omzet; wereldwijd n° 1), deeltjesversnellers (40,2%) gebruikt voor de productie van radio-isotopen (cyclotrons) en voor de ontwikkeling van sterilisatie- en ionisatieoplossingen (Rhodotron®); - dosimetrie-apparatuur en -oplossingen (10,6%; wereldwijd nr. 1): meet- en analyse-instrumenten voor de doses van straling en radiotherapie en medische beeldvorming. De geografische verdeling van de omzet is als volgt: België (2,3%), Verenigde Staten (34%), China (11,6%), Duitsland (6,5%), India (5,8%) en andere (39,8%).
Employees
2,039
Date Price Change Volume
26-08-06 US$19.00 0.00% 1,000
26-08-05 US$19.00 +5.97% 2,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
16.00EUR
Average target price
17.12EUR
Spread / Average Target
+7.03%

Annual profits - Rate of surprise